Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech company specializing in the development of innovative intranasal ...
Compass Therapeutics says a treatment evaluating its cancer treatment didn’t meet the secondary endpoint for an unexpected ...
Patent covers proprietary 2nd generation Thailanstatin analog payload designed for use in ADCs (antibody-drug conjugates) ...
Epitopea, a transatlantic biotech developing off-the-shelf, durable, RNA-based cancer immunotherapies, today announced that ...
NanoTess, a biotechnology startup which makes innovative catalytic healing solutions, is receiving a Government of Canada investment grant to prepare its commercialized civilian technology for defence ...
Agrospectrum Asia on MSN
Open Yeast Platform could lower barriers to entry and accelerate B2B biotech commercialization
Proposed hub at Hong Kong–Shenzhen Innovation and Technology Park targets regional and global research networks Pinnacle Food ...
New data demonstrate that transgenic American chestnuts produce significantly smaller blight cankers than their ...
Study published in SCIE-indexed international journal Molecular Neurobiology Three intravenous infusions at four-week ...
New preclinical data, independently presented in two posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting, show positive effects of opaganib[1] ...
Crucially, while the description notes that the laptop was “sealed in the presence of above witnesses”, suggesting compliance ...
The companies’ contrasting strategies are a clear indication that Anthropic and OpenAI disagree on how they should handle ...
Rotating detonation rocket engines work differently than traditional rockets to maximize thrust while using less fuel—an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results